Annual Retained Earnings:
$359.87M+$269.32M(+297.43%)Summary
- As of today, HALO annual retained earnings is $359.87 million, with the most recent change of +$269.32 million (+297.43%) on December 31, 2024.
- During the last 3 years, HALO annual retained earnings has risen by +$418.78 million (+710.86%).
- HALO annual retained earnings is now at all-time high.
Performance
HALO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
$361.03M-$116.93M(-24.46%)Summary
- As of today, HALO quarterly retained earnings is $361.03 million, with the most recent change of -$116.93 million (-24.46%) on June 30, 2025.
- Over the past year, HALO quarterly retained earnings has increased by +$100.42 million (+38.53%).
- HALO quarterly retained earnings is now -24.46% below its all-time high of $477.96 million, reached on March 31, 2025.
Performance
HALO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
HALO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +297.4% | +38.5% |
| 3Y3 Years | +710.9% | +1411.8% |
| 5Y5 Years | +159.6% | +161.8% |
HALO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +710.9% | -24.5% | +449.6% |
| 5Y | 5-Year | at high | +159.6% | -24.5% | +165.9% |
| All-Time | All-Time | at high | +159.6% | -24.5% | +155.6% |
HALO Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $361.03M(-24.5%) |
| Mar 2025 | - | $477.96M(+32.8%) |
| Dec 2024 | $359.87M(+297.4%) | $359.87M(-9.5%) |
| Sep 2024 | - | $397.63M(+52.6%) |
| Jun 2024 | - | $260.62M(+55.7%) |
| Mar 2024 | - | $167.37M(+84.8%) |
| Dec 2023 | $90.55M(-36.8%) | $90.55M(-59.3%) |
| Sep 2023 | - | $222.28M(+58.3%) |
| Jun 2023 | - | $140.45M(+113.8%) |
| Mar 2023 | - | $65.69M(-54.1%) |
| Dec 2022 | $143.22M(+343.1%) | $143.22M(+67.5%) |
| Sep 2022 | - | $85.52M(+258.1%) |
| Jun 2022 | - | $23.88M(+1896.7%) |
| Mar 2022 | - | $1.20M(+102.0%) |
| Dec 2021 | -$58.91M(+87.6%) | -$58.91M(+53.1%) |
| Sep 2021 | - | -$125.68M(+63.3%) |
| Jun 2021 | - | -$342.27M(+21.1%) |
| Mar 2021 | - | -$433.73M(+8.6%) |
| Dec 2020 | -$474.59M(+21.4%) | -$474.59M(+13.4%) |
| Sep 2020 | - | -$547.76M(+6.2%) |
| Jun 2020 | - | -$583.96M(+4.2%) |
| Mar 2020 | - | -$609.78M(-1.0%) |
| Dec 2019 | -$603.68M(-13.6%) | -$603.68M(-6.0%) |
| Sep 2019 | - | -$569.28M(-4.6%) |
| Jun 2019 | - | -$544.27M(-2.8%) |
| Mar 2019 | - | -$529.64M(+0.3%) |
| Dec 2018 | -$531.44M(-1.7%) | -$531.44M(-0.4%) |
| Sep 2018 | - | -$529.31M(-5.6%) |
| Jun 2018 | - | -$501.46M(-4.8%) |
| Mar 2018 | - | -$478.57M(+8.4%) |
| Dec 2017 | -$522.37M(+10.8%) | -$522.37M(+19.2%) |
| Sep 2017 | - | -$646.25M(+0.4%) |
| Jun 2017 | - | -$649.00M(-5.0%) |
| Mar 2017 | - | -$618.24M(-5.6%) |
| Dec 2016 | -$585.34M(-21.3%) | -$585.34M(-4.9%) |
| Sep 2016 | - | -$557.96M(-5.5%) |
| Jun 2016 | - | -$529.01M(-5.4%) |
| Mar 2016 | - | -$502.13M(-4.0%) |
| Dec 2015 | -$482.66M(-7.2%) | -$482.66M(+0.9%) |
| Sep 2015 | - | -$486.98M(-5.3%) |
| Jun 2015 | - | -$462.52M(+0.6%) |
| Mar 2015 | - | -$465.54M(-3.4%) |
| Dec 2014 | -$450.43M(-17.9%) | -$450.43M(-1.2%) |
| Sep 2014 | - | -$445.15M(-4.8%) |
| Jun 2014 | - | -$424.87M(-4.0%) |
| Mar 2014 | - | -$408.60M(-6.9%) |
| Dec 2013 | -$382.05M | -$382.05M(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | -$360.07M(-5.7%) |
| Jun 2013 | - | -$340.77M(-7.2%) |
| Mar 2013 | - | -$317.86M(-6.5%) |
| Dec 2012 | -$298.57M(-21.9%) | -$298.57M(-1.5%) |
| Sep 2012 | - | -$294.17M(-7.3%) |
| Jun 2012 | - | -$274.16M(-5.4%) |
| Mar 2012 | - | -$260.14M(-6.2%) |
| Dec 2011 | -$245.02M(-8.8%) | -$245.02M(-8.1%) |
| Sep 2011 | - | -$226.61M(+2.2%) |
| Jun 2011 | - | -$231.77M(+1.3%) |
| Mar 2011 | - | -$234.89M(-4.3%) |
| Dec 2010 | -$225.25M(-31.0%) | -$225.25M(-8.1%) |
| Sep 2010 | - | -$208.36M(-6.3%) |
| Jun 2010 | - | -$195.95M(-6.6%) |
| Mar 2010 | - | -$183.80M(-6.9%) |
| Dec 2009 | -$172.01M(-51.4%) | -$172.01M(-7.9%) |
| Sep 2009 | - | -$159.35M(-9.6%) |
| Jun 2009 | - | -$145.44M(-13.3%) |
| Mar 2009 | - | -$128.38M(-13.0%) |
| Dec 2008 | -$113.65M(-74.9%) | -$113.65M(-17.4%) |
| Sep 2008 | - | -$96.82M(-12.6%) |
| Jun 2008 | - | -$85.95M(-14.7%) |
| Mar 2008 | - | -$74.95M(-15.3%) |
| Dec 2007 | -$65.00M(-58.1%) | -$65.00M(-15.5%) |
| Sep 2007 | - | -$56.29M(-14.3%) |
| Jun 2007 | - | -$49.26M(-10.8%) |
| Mar 2007 | - | -$44.46M(-8.2%) |
| Dec 2006 | -$41.10M(-56.0%) | -$41.10M(-11.9%) |
| Sep 2006 | - | -$36.72M(-11.0%) |
| Jun 2006 | - | -$33.07M(-10.8%) |
| Mar 2006 | - | -$29.84M(-13.2%) |
| Dec 2005 | -$26.35M(-101.6%) | -$26.35M(-15.4%) |
| Sep 2005 | - | -$22.83M(-19.3%) |
| Jun 2005 | - | -$19.13M(-17.6%) |
| Mar 2005 | - | -$16.27M(-24.4%) |
| Dec 2004 | -$13.07M(-7004.3%) | -$13.07M(-23.4%) |
| Sep 2004 | - | -$10.59M(-44.3%) |
| Jun 2004 | - | -$7.34M(-39.4%) |
| Mar 2004 | - | -$5.26M(-2761.4%) |
| Dec 2003 | -$184.00K(-75.4%) | -$184.00K(-41.5%) |
| Sep 2003 | - | -$130.00K(-7.8%) |
| Jun 2003 | - | -$120.60K(-5.1%) |
| Mar 2003 | - | -$114.80K(-9.4%) |
| Dec 2002 | -$104.90K(-164.2%) | -$104.90K(-77.8%) |
| Sep 2002 | - | -$59.00K(-27.2%) |
| Jun 2002 | - | -$46.40K(-53.1%) |
| Mar 2002 | - | -$30.30K |
| Dec 2001 | -$39.70K | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual retained earnings year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly retained earnings year-on-year change?
What is Halozyme Therapeutics, Inc. annual retained earnings?
The current annual retained earnings of HALO is $359.87M
What is the all-time high annual retained earnings for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual retained earnings is $359.87M
What is Halozyme Therapeutics, Inc. annual retained earnings year-on-year change?
Over the past year, HALO annual retained earnings has changed by +$269.32M (+297.43%)
What is Halozyme Therapeutics, Inc. quarterly retained earnings?
The current quarterly retained earnings of HALO is $361.03M
What is the all-time high quarterly retained earnings for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly retained earnings is $477.96M
What is Halozyme Therapeutics, Inc. quarterly retained earnings year-on-year change?
Over the past year, HALO quarterly retained earnings has changed by +$100.42M (+38.53%)